Aeterna: Final Phase 3 Results Show AEZS-130 Safe, Effective In Diagnosing AGHD

Aeterna Zentaris Appoints David Dodd As President And CEO - Quick Facts

AEZS, BLRX Move Up, ASTX, PFE Hit New Highs, ACT Buys Peace, MEIP To Watch Out

Aeterna Zentaris' Disorazol Conjugates Study Data 'Encouraging' - Quick Facts

Aeterna Zentaris And Ergomed Sign Deal For AEZS-108 In Endometrial Cancer

Trade AEZS now with

6/26/2012 7:39 AM ET

Aeterna Zentaris Inc. (AEZS: Quote,AEZ.TO: Quote) said that final Phase 3 results for its oral ghrelin agonist, AEZS-130, show that the drug is safe and effective in diagnosing adult growth hormone deficiency, or AGHD.

The multicenter open label study was originally designed as a cross-over trial of AEZS-130 vs growth hormone-releasing hormone (GHRH)+L-Arginine (ARG) in AGHD patients and in controls, matched for body mass index, estrogen status, gender and age. After 43 AGHD patients and 10 controls had been tested, GHRH became unavailable. The study was completed by testing 10 more AGHD patients and 38 controls with AEZS-130 alone.

The objective of the clinical trial was to determine the efficacy and safety of AEZS-130 in the diagnosis of AGHD.

Click here to receive FREE breaking news email alerts for AEterna Zentaris Inc and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

<<Previous 152 Articles Next>>

Editors Pick

Adobe Profit Tops Estimate

Publishing and design software maker Adobe Systems Inc. said Tuesday after the markets closed that its second quarter profit fell 66% from last year, hurt by lower revenue as well as higher costs and expenses. However, the company's quarterly earnings per share, excluding items, came in above analysts' expectations and its quarterly revenue was in line with analysts' forecast.

Stocks Show Strong Upward Move Ahead Of Fed Announcement - U.S. Commentary

Stocks showed a strong upward move over the course of the trading day on Tuesday, adding to the gains posted in the previous session. The rally came even as traders expressed some uncertainty ahead of tomorrow's Federal Reserve announcement. The major averages gave back some ground going into the close but remained firmly in positive territory.

Boehner Indicates Immigration Bill Must Have Majority GOP Support

In a potential roadblock to comprehensive immigration reform legislation, House Speaker John Boehner, R-Ohio, indicated Tuesday that he would not bring a bill to the floor unless it is supported by a majority of House Republicans.